Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$318.70 USD

318.70
814,302

+3.38 (1.07%)

Updated May 24, 2024 04:00 PM ET

After-Market: $318.64 -0.06 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 12% (31 out of 250)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Why HCA Healthcare (HCA) is a Top Stock for the Long-Term

by Zacks Equity Research

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Abhinab Dasgupta headshot

3 Medical Stocks to Buy as the Sector Continues to Grow

by Abhinab Dasgupta

HCA Healthcare (HCA), ADMA Biologics (ADMA) and Exelixis (EXEL) are three medical stocks that you can look into as the sector continues to sustain its end-of-the-year momentum.

Is HCA (HCA) a Buy as Wall Street Analysts Look Optimistic?

by Zacks Equity Research

Based on the average brokerage recommendation (ABR), HCA (HCA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

HCA Healthcare, Inc. (HCA) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Sanghamitra Saha headshot

3 Sector ETFs & Stocks to Bet on Superb January Jobs Data

by Sanghamitra Saha

The U.S. economy added 353,000 for the month, much better than the Dow Jones estimate for 185,000 (as quoted on CNBC).

Inspire Medical (INSP) Q4 Earnings Top Estimates, Gross Margin Up

by Zacks Equity Research

Inspire Medical's (INSP) U.S. region witnesses strong revenue growth in the fourth quarter.

Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Tirthankar Chakraborty headshot

4 Top Stocks to Buy for Attractive Earnings Growth

by Tirthankar Chakraborty

Invest in stocks such as HCA Healthcare (HCA), Powell Industries (POWL), Axos Financial (AX), and Eagle Materials (EXP) for solid earnings growth.

HCA Healthcare (HCA) Is Up 9.17% in One Week: What You Should Know

by Zacks Equity Research

Does HCA Healthcare (HCA) have what it takes to be a top stock pick for momentum investors? Let's find out.

How to Find Strong Buy Medical Stocks Using the Zacks Rank

by Zacks Equity Research

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.

Derek Lewis headshot

Buyback Bonanza: 3 Buy-Rated Companies Scooping Up Shares

by Derek Lewis

A common way that companies amplify shareholder value is through implementing share buybacks. And recently, these three companies have authorized precisely that.

Ensign Group (ENSG) Q4 Earnings Beat, Stock Up 5%

by Zacks Equity Research

Ensign Group's (ENSG) fourth-quarter results were aided by improved same-store occupancy and an increase in rental revenues. Management expects 2024 adjusted EPS within $5.29-$5.47.

If You Invested $1000 in HCA Healthcare 10 Years Ago, This Is How Much You'd Have Now

by Zacks Equity Research

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Surmodics (SRDX) Q1 Earnings Top Estimates, Revises FY24 View

by Zacks Equity Research

Surmodics (SRDX) reports a solid fiscal first quarter top line on the back of robust segmental revenues.

Best Momentum Stocks to Buy for February 2nd

by Zacks Equity Research

BK, HCA and HOOK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 2, 2023.

New Strong Buy Stocks for February 2nd

by Zacks Equity Research

USM, BK, KOF, HCA and AX have been added to the Zacks Rank #1 (Strong Buy) List on February 2, 2023.

Shaun Pruitt headshot

3 Value Stocks to Buy After Beating Q4 Earnings Expectations

by Shaun Pruitt

Stronger-than-expected Q4 earnings on Tuesday helped rectify the notion that these stocks are undervalued making now an ideal time to buy.

Sheraz Mian headshot

Top Research Reports for Abbott, T-Mobile & Booking

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).

BD (BDX) Q1 Earnings Surpass Estimates, Margins Contract

by Zacks Equity Research

BD's (BDX) overall top line benefits from revenue growth in the majority of its segments and both geographic regions in the fiscal first quarter.

Accuray (ARAY) Q2 Earnings Lag Estimates, Gross Margin Contracts

by Zacks Equity Research

Despite robust Services revenues, Accuray (ARAY) reports dismal second-quarter fiscal 2024 results.

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Is HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how HCA Healthcare (HCA) and HealthEquity (HQY) have performed compared to their sector so far this year.

Company News for Jan 31, 2024

by Zacks Equity Research

Companies in The News Are: HCA,SYY,MSCI,NUE

Universal Health Services, Inc. (UHS) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.